Product Information
PROCHLORPERAZINE 10 MG TAB is a generic product labeled by Bionpharma Inc., priced at $0.1621 per EA under NDC 69452047220. Its NADAC has been published 74 times since May 7, 2025.
FDA first approved this application on Apr 4, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Bionpharma Inc.NDC
69452047220
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PROCHLORPERAZINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA217478FDA Approved
4/4/2023
TE Code
AB
On Market Since
1/31/2025
Pharmacological Classes
Price Statistics
The NADAC for PROCHLORPERAZINE 10 MG TAB has been published 74 times since May 7, 2025, and over the history we have for it it has declined 25.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1621 per EA |
|---|---|
| All-time high | $0.2173 (May 14, 2025) |
| All-time low | $0.1621 (Sep 23, 2026) |
| 52-week high | $0.2036 |
| 52-week low | $0.1621 |
| Median price | $0.1847 |
| Average price | $0.1873 |
| Largest weekly change | +11.8% (Aug 20, 2025) |
| Weeks tracked | 74 |
| Tracking since | May 7, 2025 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bionpharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Prochlorperazine Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROCHLORPERAZINE 10 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for PROCHLORPERAZINE 10 MG TAB, manufactured by Bionpharma Inc., is $0.1621 per EA (NDC 69452047220), effective Sep 30, 2026.
How has the price of PROCHLORPERAZINE 10 MG TAB changed over time?
Over the history we have for it, the NADAC for PROCHLORPERAZINE 10 MG TAB has declined 25.4%. It has been tracked across 74 weekly CMS publications since May 7, 2025.
What are the highest and lowest recorded NADAC prices for PROCHLORPERAZINE 10 MG TAB?
Since May 7, 2025, the NADAC for PROCHLORPERAZINE 10 MG TAB has ranged from a low of $0.1621 (Sep 23, 2026) to a high of $0.2173 (May 14, 2025), with a median of $0.1847 per EA.
Are there cheaper alternatives to PROCHLORPERAZINE 10 MG TAB?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PROCHLORPERAZINE 10 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures PROCHLORPERAZINE 10 MG TAB?
PROCHLORPERAZINE 10 MG TAB (NDC 69452047220) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.